![Point-of-care manufacturing, scalable manufacturing, and bringing the cost down [can help].](https://cdn.sanity.io/images/0vv8moc6/cancernetwork/55a279b707f0cd71181a5efa8b3d3cd864555701-3002x1684.png?w=350&fit=crop&auto=format)
- Oncology NEWS International Vol 6 No 10
- Volume 6
- Issue 10
‘Sprinkle’ Method of Giving Kadian Capsules Approved
WILMINGTON, Del-The FDA has cleared an alternative method of administration of the pellets contained in Zeneca’s Kadian (morphine sulfate sustained release) capsules.
WILMINGTON, DelThe FDA has cleared an alternative method of administration of the pellets contained in Zenecas Kadian (morphine sulfate sustained release) capsules.
Rather than being swallowed whole, now the capsules may be opened and the entire contents sprinkled on a small amount of applesauce immediately prior to ingestion. The pellets should not be chewed, crushed, or dissolved due to risk of overdose, the company said.
In a study of healthy volunteers, Kadian pellets sprinkled over applesauce were found to be bioequivalent to Kadian capsules swallowed whole with apple-sauce under fasting conditions. With the sprinkle administration, patients should consume the entire portion and should not divide the applesauce into separate doses. Other foods for use with Kadian pellets have not been tested in patients.
Kadian is prescribed for the management of moderate-to-severe chronic pain when treatment with an opioid analgesic is indicated for more than a few days.
The recent approval of Kadian in sprinkle-supplement form allows patients who experience moderate-to-severe pain, and have difficulty swallowing capsules or tablets, 24-hour pain control with the option of a single dose, said oncologist Robert Kerr, MD, of Southwest Regional Cancer Center, Austin, Tex.
Articles in this issue
about 28 years ago
Toremifene, Tamoxifen Equivalent in Advanced Breast Cancerabout 28 years ago
Fluorescence ‘LIFE’ Images Spot Occult Lung Cancer Lesionsabout 28 years ago
The Issue That Won’t Go Away: Screening Mammographyabout 28 years ago
News in Brief...about 28 years ago
Concurrent Better Than Sequential Chemo-RT in NSCLCabout 28 years ago
Consumer Version of Merck & Co’s Famous Manual Is Availableabout 28 years ago
A Talk With Dr. Richard Klausner, Head of the NCIabout 28 years ago
Age Is a Factor in Survival of SqCC of the Head and Neckabout 28 years ago
Symptom-Based Staging of Head & Neck CancerNewsletter
Stay up to date on recent advances in the multidisciplinary approach to cancer.